STOCK TITAN

argenx (ARGX) 6-K links June 2025 press release to S-8 filings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

argenx SE (ARGX) has filed a Form 6-K for June 2025. The filing’s sole purpose is to furnish a press release dated 20 June 2025, attached as Exhibit 99.1 and incorporated by reference into the company’s outstanding Form S-8 registration statements (File Nos. 333-225375, 333-258253 and 333-274721). No financial statements, earnings figures, or transactional details are included in the filing, and the text does not disclose the subject matter of the referenced press release. The document therefore serves an administrative function, ensuring the press release is part of the SEC record and automatically updates the company’s registration statements.

Positive

  • None.

Negative

  • None.

Insights

TL;DR – Routine administrative 6-K; no new financial information disclosed.

This Form 6-K merely places a 20 June 2025 press release into the SEC database and links it to existing S-8 registration statements. Because the release itself is not included in the text provided, investors receive no incremental insight into operations, strategy, or financial performance. Such housekeeping filings are common for foreign private issuers and typically have negligible market impact unless the attached exhibit contains material news. In the absence of that exhibit here, the filing should be viewed as neutral.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of June 2025

 

Commission File Number: 001-38097

 

 

ARGENX SE

(Translation of registrant’s name into English)

 

 

Laarderhoogtweg 25
1101 EB Amsterdam, the Netherlands

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x     Form 40-F  ¨

  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

 

 

EXPLANATORY NOTE

 

On June 20, 2025, argenx SE (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

The information contained in this Current Report on Form 6-K, including Exhibit 99.1, shall be deemed to be incorporated by reference into the Company’s Registration Statements on Forms S-8 (File Nos. 333-225375, 333-258253, and 333-274721), and to be part thereof from the date on which this Current Report on Form 6-K is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Exhibit   Description
     
99.1   Press Release June 20, 2025

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ARGENX SE
     
Date: June 20, 2025 By: /s/ Hemamalini (Malini) Moorthy
    Name: Hemamalini (Malini) Moorthy
    Title: General Counsel

 

 

 

FAQ

Why did argenx (ARGX) file a Form 6-K on 20 June 2025?

To furnish a 20 June 2025 press release as Exhibit 99.1 and incorporate it into existing S-8 registration statements.

Does the 6-K contain new financial or earnings data for ARGX?

No. The filing is administrative and includes no financial metrics, earnings results, or guidance.

Are any major transactions or partnerships disclosed in this ARGX 6-K?

No major transactions are mentioned; the document only references an attached press release.

Is the attached press release (Exhibit 99.1) included in the filing text?

It is referenced but the content of the press release is not provided in the filing excerpt.

Will this 6-K materially impact ARGX’s share price?

Unlikely, as the filing itself introduces no substantive information beyond administrative incorporation.
Argenx Se

NASDAQ:ARGX

View ARGX Stock Overview

ARGX Rankings

ARGX Latest News

ARGX Latest SEC Filings

ARGX Stock Data

45.82B
60.91M
Biotechnology
Healthcare
Link
Netherlands
Amsterdam